When is treatment clinically relevant compared to placebo for studies in Nocturia?

Holm-Larsen T1, van Der Meulen E2, Nørgaard J P2, Kold Olesen T2

Abstract Category

Nocturia

Abstract 343
Nocturia
Scientific Podium Poster Session 21
Wednesday 22nd October 2014
17:35 - 17:40
Room B2
Clinical Trial Hormone Therapy Nocturia Quality of Life (QoL) Voiding Dysfunction
1. Pharma Evidence, 2. Ferring Pharmaceuticals
Presenter
T

Tove Holm-Larsen

Links

Abstract